Suppliers for Lab polyclonals Our used monoclonals in Pubmed.
Suppliers for Lab Assays Our used polyclonals in Pubmed.
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group
urpose: The medium-risk (IR) prostate cancer (PCa) are a heterogeneous group in terms of prognosis. For unfavorable or favorable IR PCa treated with radiotherapy, the
Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers
Background: Provider implicit bias could negatively affect the doctor-patient communication. In this study, the authors measured implicit bias training in pediatric oncology providers and exposure
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
Background: The results of operations are not planned for bone sarcomas has not often discussed. However, it is important to recognize patterns, treatment, and clinical
Improving direct pharmacist counseling rates for oral oncolytic medications at an outpatient oncology clinic
Background: Because of the increasing prevalence of the use of oncolytic orally to patients with malignancies, implementation and monitoring strategies to improve patient safety has
Nurse-initiated protocols in the emergency department management of pediatric oncology patients with fever and suspected neutropenia: a scoping review protocol
Objective: To provide an overview of the evidence for nurse-initiated protocol in the emergency management of pediatric oncology patients with fever and neutropenia is suspected.